Haemophilus influenzae and smoking-related obstructive airways disease
Diana C Otczyk1, Robert L Clancy2, Allan W Cripps1
1School of Medicine, Griffith Health Institute, Griffith Health, Griffith University, Gold Coast, Queensland, Australia; 2Immunology Unit, Hunter Area Pathology Service and University of Newcastle, Newcastle, New South Wales, Australia
Background: Intralumenal bacteria play a critical role in the pathogenesis of acute infective episodes and airway inflammation. Antigens from colonizing bacteria such as nontypeable Haemophilus influenzae (NTHi) may contribute to chronic lung disease through an immediate hypersensitivity response. The objective of this study was to determine the presence of specific NTHi-IgE antibodies in subjects with chronic bronchitis (CB) and COPD who had smoked.
Methods: Serum, sputum, and saliva samples were collected from subjects with CB and moderate–severe COPD and healthy aged-matched controls. Total IgE and specific NTHi IgE were measured by enzyme linked immmunosorbent assay. Throat swabs were examined for the presence of NTHi.
Results: The results demonstrate that: i) specific NTHi IgE antibodies occur at a low level in healthy subjects; ii) those with both CB and moderate–severe COPD have elevated specific NTHi IgE antibody compared with healthy controls, with higher levels in those with most severe disease; iii) IgE levels are greater in those with moderate–severe COPD than in those with CB. They demonstrate specific NTHi IgE antibody is regularly found at higher than normal levels in COPD.
Conclusion: The detection of IgE antibody to colonizing bacteria in all subjects with CB or moderate–severe COPD identifies a possible mechanism of bronchospasm in these subjects amenable to specific intervention therapy.
Keywords: nontypeable Haemophilus influenza, chronic bronchitis, chronic obstructive pulmonary disease, IgE, smoking
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]
Readers of this article also read:
Carr ME, Tortella BJ
Published Date: 3 September 2015
Roy K, Kanwar RK, Kanwar JR
Published Date: 26 August 2015
Relapsed Hodgkin lymphoma in adolescents: focus on current high-dose chemotherapy and autologous stem cell transplant
Guilcher GM, Stewart DA
Published Date: 8 May 2014
Orth P, Rey-Rico A, Venkatesan JK, Madry H, Cucchiarini M
Published Date: 16 January 2014
Published Date: 4 April 2013
Published Date: 8 December 2011
Topical nonsteroidal anti-inflammatory drugs for management of osteoarthritis in long-term care patients
Argoff CE, Gloth FM
Published Date: 20 September 2011
Mösges R, Nematian-Samani M, Eichel A
Published Date: 27 July 2011
Diclofenac sodium topical solution with dimethyl sulfoxide, a viable alternative to oral nonsteroidal anti-inflammatories in osteoarthritis: review of current evidence
Fuller P, Roth SH
Published Date: 11 July 2011
Niklas Schuelert, Fiona A Russell, Jason J McDougall
Published Date: 6 February 2011